EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anal intraepithelial neoplasia screening in women from the largest center for lower genital tract disease in China

Lu Zhang iD, Yixin Sun, Jianyu Chen, Xiang Tao, Long Sui iD, Qing Cong

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Lu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cervical Disease Center, Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Anus Neoplasms, Papillomavirus Infections, Early Detection of Cancer, Carcinoma in Situ. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to provide comprehensive clinical screening data for anal intraepithelial neoplasia (AIN). This study included 312 patients who underwent high‐resolution anoscopy (HRA) examinations between January 1, 2020 and April 15, 2024. Clinical data, including demographic information, clinical history, cytology/high‐risk human papilloma virus (hrHPV) results, and HRA records, were analyzed. The median age of all patients was 42 years (interquartile range: 33–52 years). Approximately 26.3% reported a history of VIN2/3+, 13.5% had a history of VaIN2/3+, 29.8% had a history of CIN2/3+, 44.6% had persistent cervical HPV16 infection, and 12.5% had immune suppression. Among the 312 patients, 14.4% were diagnosed with AIN2/3, 25.0% with AIN1 and 60.6% were normal. Anal cytological abnormalities were found in 41.3% of all patients, with a significantly higher rate in AIN2/3 patients than in ≤AIN1, 71.1% versus 36.3%, p < 0.001. The hrHPV positivity rate was 89.7%, with HPV16 being the most prevalent. The complete agreement rate for HRA impressions was 79.5%. Multi‐variable analysis revealed immune suppression (odds ratio [OR]: 3.47, 95% confidence interval [CI]: 1.42–8.5) and VIN2/3+ (OR: 2.82, 95% CI: 1.27–6.28) were independent risk factors for AIN2/3. Abnormal cytology results (OR: 3.3, 95% CI: 1.52–7.17) and anal HPV16 infection (OR: 3.2, 95% CI: 1.26–8.12) demonstrated similar ORs for AIN2/3. Early screening for AIN2/3+ is crucial in Chinese women with lower genital tract precancerous and cancerous lesions, particularly in those with VIN2/3+ and immune suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anus NeoplasmsPapillomavirus InfectionsEarly Detection of CancerCarcinoma in SituHumansFemaleMiddle AgedAdultChinaRisk FactorsHuman papillomavirus 16

Stichwörter der Autor:innen

ChinaHPV testinganal intraepithelial neoplasiacytologyhigh‐resolution anoscopyscreening

Autor:innen und Institutionen

  • Cervical Disease Center, Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

ORCID-Profile: Lu Zhang, Long Sui

Zitieren

APA

Zhang, L., Sun, Y., Chen, J., Tao, X., Sui, L., & Cong, Q. (2024). Anal intraepithelial neoplasia screening in women from the largest center for lower genital tract disease in China. Journal of Medical Virology. https://doi.org/10.1002/jmv.29747

Vancouver

Zhang L, Sun Y, Chen J, Tao X, Sui L, Cong Q. Anal intraepithelial neoplasia screening in women from the largest center for lower genital tract disease in China. Journal of Medical Virology. 2024. doi:10.1002/jmv.29747

BibTeX
@article{Zhang2024,
  author = {Zhang, Lu and Sun, Yixin and Chen, Jianyu and Tao, Xiang and Sui, Long and Cong, Qing},
  title = {Anal intraepithelial neoplasia screening in women from the largest center for lower genital tract disease in China},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29747}
}
Kostenlos starten →